Jamis Gouge, MD
Critical Care Medicine · Salt Lake City, UTNPI 1750777355
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 34 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 13 manufacturers reported payments, led by AstraZeneca at 29.7% of the total. Reporting peaked in 2021 at $624 and has fallen 76.3% since, to $148 in 2025.
Across 34 payments — averaging $43.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$443
- GSK$247
- Johnson & Johnson$151
- Pulmonx Corporation$148
- Novartis$125
- Gilead$124
- plus $254 from 7 others
What the payments were for
- Food & beverage$1,492100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 7 | $443 |
| GSK | 2 | $247 |
| Johnson & Johnson | 8 | $151 |
| Pulmonx Corporation | 1 | $148 |
| Novartis | 1 | $125 |
| Gilead | 1 | $124 |
| E.r. Squibb & Sons, L.L.C. | 5 | $78 |
| Melinta Therapeutics, LLC | 4 | $56 |
| Intuitive Surgical | 1 | $43 |
| UCB, Inc. | 1 | $23 |
| La Jolla Pharmaceutical Company | 1 | $22 |
| Aurinia Pharma U.S., Inc. | 1 | $17 |
| Pfizer | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LOKELMA$250
- CHARTIS CATHETER$148
- ZEPHYR DELIVERY CATHETER$148
- ZEPHYR ENDOBRONCHIAL VALVE$148
- PULMONX CHARTIS TABLET CONSOLE$148
- LEQVIO$125
- FARXIGA$124
- JEMPERLI$124
- Yescarta$124
- OJJAARA$122
How this compares
$1,492 in reported general payments places this provider in the 80th percentile of 44 critical care medicine providers in Utah.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 13 | $226 |
Paid to pharmacies, not to this prescriber.
Other critical care medicine in Salt Lake City
- Laura FryeSalt Lake City$66K
- Theodore LiouSalt Lake City$14K
- James RasmussenSalt Lake City$3K
- James OrmeSalt Lake City$3K
- Cheryl PirozziSalt Lake City$1K
- Nathan HattonSalt Lake City$763
- Nicholas LevinSalt Lake City$500
- Matthew GlickSalt Lake City$443
- Matthew MorrellSalt Lake City$392
- Benjamin TasevacSalt Lake City$338
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.